We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ITX:BMEIndustria de Diseno Textil, S.A. Analysis

Data as of 2026-06-17 - not real-time

€55.94

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

ITX trades at €55.94, comfortably above its 20‑day (€53.59), 50‑day (€52.49) and 200‑day (€51.62) moving averages, confirming a bullish price structure. The MACD line sits at 1.23 versus a signal of 0.94, generating a bullish histogram, while the 14‑day RSI of 63 indicates momentum still has room before reaching overbought levels. Volume is on an upward trend, supporting the price advance toward the technical resistance near €57.32, with a solid support cushion around €49.26. The market’s fear‑greed gauge reads “Extreme Greed” at 92, suggesting strong investor appetite.
Fundamentally, the group delivers robust profitability—gross margin of 56 %, operating margin of 20 % and a ROE of 34 %—and maintains a healthy balance sheet with €10.8 bn cash against €6.0 bn debt (net‑cash positive). However, valuation multiples are lofty, with a trailing P/E of 27.7, forward P/E of 23.5 and a price‑to‑book of 9.2, implying the stock is at least fairly valued if not slightly stretched. The dividend yield of 1.16 % and a 57 % payout ratio appear sustainable given the strong cash generation, and analysts (24) collectively rate the stock as a “Buy” with a median price target of €61. These dynamics point to upside potential of roughly 5‑6 % while keeping downside risk limited.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Price above all major moving averages
  • Bullish MACD and rising volume
  • Strong profit margins and cash position

Medium Term

1–3 years
Neutral
Model confidence: 8/10

Key Factors

  • Sustainable dividend yield
  • High ROE and diversified global footprint
  • Elevated valuation multiples temper upside

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Resilient brand portfolio with global exposure
  • Consistently high operating margins
  • Net‑cash strength supporting growth and shareholder returns

Key Metrics & Analysis

Financial Health

Revenue Growth5.80%
Profit Margin15.59%
P/E Ratio27.7
ROE33.96%
ROA14.31%
Debt/Equity31.82
P/B Ratio9.2

Technical Analysis

TrendBullish
RSI63.4
Support€49.26
Resistance€57.32
MA 20€53.59
MA 50€52.49
MA 200€51.62
MACDBullish
VolumeIncreasing
Fear & Greed Index92.13

Valuation

Target Price€59.14
Upside/Downside5.72%
GradeFair
TypeBlend
Dividend Yield1.16%

Risk Assessment

Beta0.33
Volatility26.02%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.